Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-000519
Filing Date
2025-01-03
Accepted
2025-01-03 17:00:12
Documents
1
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form4-01032025_050103.html 4  
1 form4-01032025_050103.xml 4 4237
  Complete submission text file 0001415889-25-000519.txt   5616
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
Quaggin Susan E (Reporting) CIK: 0001997505 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35565 | Film No.: 25507484